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Effect of Relaxin on Parturition in Ruminants
Abstract
The biology of relaxin differs in many respects between ruminants and nonruminants. Immunoreactive blood
concentration of circulating relaxin is much less in ruminant (cattle and sheep) than in nonruminant (pigs)
farm animals. The ovaries of the pig produce abundant quantities of the hormone in late pregnancy, whereas
tissue sources of relaxin are not clearly defined in sheep and cattle. Relaxin facilitates parturition by cervical
dilation and pelvic canal expansion in several mammalian species. Relaxin injected intramuscularly during late
pregnancy can cause earlier parturition in cattle, but in sheep limited evidence indicates it does not induce
earlier delivery than seen in diluent-treated controls. Intravenous infusion of increasing dosages of relaxin in
beef heifers the last days of pregnancy decreased plasma progesterone concentration compared with
phosphate buffer controls, but oxytocin plasma concentrations remained similar throughout the
posttreatment period. Although continuous intravenous infusion of relaxin depressed blood levels of
progesterone, it did not result in earlier parturition than seen in the diluent treated controls. Thus, the timing
and method of relaxin administration during late pregnancy in ruminants affect remodelling of collagen and
pelvic canal relaxation and can result in earlier parturition.
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Summary
The biology of relaxin differs in many respects
between ruminants and nonruminants.
Immunoreactive blood concentration of
circulating relaxin is much less in ruminant
(cattle and sheep) than in nonruminant (pigs)
farm animals. The ovaries of the pig produce
abundant quantities of the hormone in late
pregnancy, whereas tissue sources of relaxin
are not clearly defined in sheep and cattle.
Relaxin facilitates parturition by cervical
dilation and pelvic canal expansion in several
mammalian species. Relaxin injected intramus-
cularly during late pregnancy can cause earlier
parturition in cattle, but in sheep limited
evidence indicates it does not induce earlier
delivery than seen in diluent-treated controls.
Intravenous infusion of increasing dosages of
relaxin in beef heifers the last days of preg-
nancy decreased plasma progesterone
concentration compared with phosphate buffer
controls, but oxytocin plasma concentrations
remained similar throughout the posttreatment
period. Although continuous intravenous
infusion of relaxin depressed blood levels of
progesterone, it did not result in earlier
parturition than seen in the diluent treated
controls. Thus, the timing and method of
relaxin administration during late pregnancy in
ruminants affect remodelling of collagen and
pelvic canal relaxation and can result in earlier
parturition.
Introduction
Induction of parturition with prostaglandin F2a(PGF2a), glucocorticoids, or their analogs often
results in a high incidence of difficult birth
(dystocia), fetal membrane retention, and reduced
fertility. Dystocia is related to insufficient dilation
of the birth canal, insufficient pelvic area, and calf
or lamb size at birth. Relaxin is a peptide hormone
with partial structural homology to insulin. It is
produced in abundant quantities in the ovaries of
late pregnant pigs, and thus provides a source of
relaxin for studies on reproduction in other farm
animal species. Although the pig is a rich source of
this hormone, only a single copy of the relaxin-like
gene corresponds to part of the relaxin A-chain in
sheep, and there is little evidence to support
biosynthesis of the hormone in cattle. Relaxin
remodels connective tissue by inducing cervical
dilation, pelvic relaxation, and separation of
interpubic ligaments in several mammalian
species. It also inhibits smooth muscle contraction
of the uterus, but in contrast, increases atrial
contractions in the heart. Thus, this hormone may
affect important metabolic functions in addition to
its actions on the reproductive system in late
pregnancy. RU 486 is a 19-norsteroid with high
affinity for progesterone receptor. It has strong
antiglucocorticoid activities. RU 486 is an
antagonist that renders progesterone biologically
inactive. Our results on the effects of relaxin alone
or in combination with an antiprogesterone
administered to cattle and sheep during late
pregnancy on parturition are summarized.
Materials and Methods
Animals
Primiparous crossbred beef heifers at the
Rhodes cattle research farm, and Holstein dairy
heifers at the dairy farm, Iowa State University,
approaching their first calving were bred by
artificial insemination at estrus (day 0). Gestation
averages 283 days in these herds. Suffolk and
Hampshire breeds of sheep were bred and
maintained at the Iowa State University Sheep
Teaching Farm. Ewes were naturally mated at
estrus (day 0). The average duration of gestation in
this flock is 150 days.
Relaxin (3,000 units per milligram) for these
experiments was extracted from the ovaries of
pregnant pigs and purified according to procedures
described by Christian Schwabe, Medical
University of South Carolina, Charleston. For
some experiments, the animals were fitted with an
indwelling cannula in the jugular vein for repeat
blood sampling. Blood samples (10 milliliters)
were collected in borosilicate culture tubes and
maintained on ice. Tubes were centrifuged at 2,000
x g for 10 minutes and plasma harvested, frozen
on dry ice and stored at -20° C until required for
radioimmunoassay of progesterone, relaxin,
oxytocin and RU 486.
The cattle and sheep were monitored
continuously for signs of imminent parturition.
Duration of gestation, exact time of calving or
lambing, degree of difficulty of birth (dystocia),
time of placenta delivery, sex and birth weight of
calves and lambs were recorded.
In cattle, relaxin was administered
intramuscularly or infused intravenously
continuously beginning six days before expected
parturition. Phosphate buffer saline (PBS) was
given by these same routes and periods of
treatment in the controls. In sheep, relaxin was
injected intramuscularly at noon on day 144; PBS
was given to the control group at the same time.
The antiprogesterone, RU 486, was administered
intramuscularly (2 mg/kg body weight in cattle; 4
mg/kg body weight in sheep) alone or in
combination with relaxin. Diluent treatment
consisted of 3 ml ethanol injected intramuscularly.
Radioimmunoassay of Hormones
Radioimmunoassay of hormones was carried
out in our laboratory with fully validated assays by
our previously published procedures. Plasma
volume ranged from 50 to 100 microliters for
these hormone assays, and all assays were carried
out in duplicate. For oxytocin, progesterone and
RU 486, the plasma samples were solvent
extracted before radioimmunoassay. Assay
sensitivity was .25 nanogram per milliliter for
progesterone, 40 picograms per milliliter for
relaxin, .01 picograms per tube for oxytocin, and
10 picograms per tube for RU 486.
Statistical Analysis
Results are expressed as mean –  standard error
(SE). Experimental units in the study were the
individual animals randomly assigned to
treatments. Hormone data were analyzed by split-
plot design using both the general linear model and
Student's t-test for comparisons between treatment
groups.
Results and Discussion
The profile of immunoreactive relaxin blood
concentration in nonruminants (pigs) remains low
during most of pregnancy, but it increases the last
days of pregnancy and reaches peak levels (i.e., 60-
90 nanogram per milliliter) a few hours before
parturition. In ruminants (cattle and sheep) relaxin
immunoreactivity is low, usually less than .20
nanogram per milliliter (i.e., 200 picograms per
milliliter) a week before parturition. In cattle, it
increases to peak concentrations of >800
picograms per milliliter on the day of parturition.
In sheep, relaxin plasma concentrations increase
with advancing gestation, from an average of .60
nanogram per milliliter reaching a peak of 3.90
nanogram per milliliter on day 146 (four days
before parturition). At parturition however, relaxin
concentration averaged only .80 nanogram per
milliliter. Thus, an antepartum relaxin surge occurs
in late pregnant ewes, but the modest amplitude of
the relaxin surge differs greatly from that seen in
nonruminants, and it occurs earlier in sheep than
pigs. There is no evidence of an endogenous
transient prepartum relaxin peak in cattle.
Administration of porcine relaxin (RLX)
intramuscularly to beef heifers five days before
expected term causes a transient, but significant (p
< .05), decrease in plasma progesterone
concentration within 90 minutes compared with
PBS-treated controls (Table 1). In late pregnant
ewes, relaxin injected intramuscularly on days 144
and 145 resulted in significantly lower plasma
concentrations of progesterone, but did not cause
significantly earlier parturition than seen in the
PBS-treated controls. During the pretreatment
period in these ewes, plasma progesterone
averaged 11 –  .6 nanogram per milliliter, but
relaxin treatment reduced (p < .05) progesterone to
8 –  .4 nanogram per milliliter. Continuous infusion
of high levels of porcine relaxin (200-700 units per
hour) beginning day 277 of pregnancy in beef
heifers significantly reduced circulating plasma
progesterone concentration, but did not result in
earlier parturition compared with PBS-infused
controls.
RU 486 treatment in cattle on days 277 and
278 of pregnancy significantly decreased (p < .05)
progesterone concentration compared with diluent-
treated controls. Likewise in sheep, RU 486
injected on days 144 and 145 of pregnancy
abruptly decreased (p < .05) circulating
progesterone concentration compared with diluent-
treated controls. Progesterone concentration in
peripheral plasma decreased by 30 hours after RU
486 treatment in cattle and sheep. At induced
parturition progesterone concentration was similar
to the diluent-treated controls (2.0 nanogram per
milliliter in cattle; 4.0 nanogram per milliliter in
sheep). Thus, a significant decrease in circulating
progesterone concentration must be obtained in
these species to result in hormone-induced or
normal parturition. The second injection of RU 486
24 hours later in cattle and sheep assured a rapid
and consistent decrease in circulating progesterone.
The concentration of relaxin and RU 486 was
monitored in peripheral blood plasma of these
hormone treated cattle and sheep during late
pregnancy (Figures 1 and 2). In cattle, plasma
concentrations of RU 486 increased abruptly
within 15 minutes after first RU 486 injection on
day 277, peaked at 7.2 nanogram per milliliter by
45 minutes, and were maintained at 5.5 nanogram
per milliliter throughout the 24-hour period. On
day 278, the second RU 486 treatment further
increased RU 486 to 14.3 nanogram per milliliter
within 30 minutes. RU 486 averaged 7.9
nanogram per milliliter on the day of induced
calving (day 279), a time when progesterone was
at basal concentration. Relaxin increased to a peak
concentration of 4.1 nanogram per milliliter within
60 minutes after relaxin injection, and decreased to
basal levels of less than .5 nanogram per milliliter
by 18 hours. Relaxin treatment on the second day
of RU 486 treatment in cattle did not result in a
further shortening of the interval to calving
compared with RU 486 treatment alone. In mul-
tiparous cows there was no incidence of dystocia at
induced parturition. In primiparous heifers the
incidence of dystocia was significantly reduced by
RU 486 treatment compared with diluent-treated
controls, but difficult calving was not completely
eliminated by this hormone treatment.
The mechanism by which relaxin promotes
cervical dilation is still poorly understood. Relaxin
acts on collagen of the cervix and pelvis and causes
relaxation by inducing the disintegration of the
collagen matrix. Several studies have indicated that
relaxin acts directly on cervical tissue as indicated
by high affinity binding of the hormone, increased
cyclic adenylyl cyclase, and decreased proline
incorporation. The results of our studies were
interpreted to indicate that relaxin promotes cervical
dilation, probably by remodeling connective tissue
collagen during late pregnancy.
Implications
Relaxin treatment of late pregnant cows and
heifers causes cervical softening and dilation
probably by remodeling collagen in cervical
tissues. Relaxin treatments were given during the
spring calving season, and there were variable
results in the timing of delivery when comparing
one season to the next. Limited results indicated
that relaxin treatment of ewes did not affect the
time of lambing. RU 486 treatment of late pregnant
cattle and sheep precisely controlled the time to
induced parturition, but did not eliminate dystocia
in primiparous heifers.
Table 1. Effect of relaxin (RLX) on pregnancy and parturition in ruminants.
Treatment Number of animal
Hours from
first treatment
to parturition
Beef cattleb PBS 16 127 –  22
3,000 U RLX 14 60 –  19**
2 x 3,000 U RLX 17 48 –  28*
Beef heifersd PBS 16 146 –  12
(Spring 1992) 2 x 5,000 U RLX 16 80 –  13**
Beef heifersd PBS 22 75 –  11
(Spring 1993) 2 x 5,000 U RLX 24 74 –  13
Beef cows Diluent 6 210 –  57
RU 486 (2 mg/kg BW) 6 55 –  3**
RU 486 + 3,000 U RLX 6 53 –  11**
Beef heifers Diluent 7 182 –  38
RU 486 (2 mg/kg BW) 7 43 –  7**
RU 486 + 3,000 U RLX 7 52 –  6**
Dairy heifersa PBS 7 125 –  34
3,000 U RLX 7 80 –  19**
2 x 3,000 U RLX 7 64 –  17**
Sheepc Diluent 8 121 –  27
3,000 U RLX 9 109 –  23
RU 486 (4 mg/kg BW) 5 31 –  2*
a
 Injection started on day 276 of gestation.
b
 Treatment started on day 278 of gestation.
c
 Injection started on day 144 of gestation.
d
 Treatment started on day 277 of gestation.
Values are mean –  SE.
*p < .05.
**p < .01.
Figure 1. (A) Peripheral plasma concentrations of RU 486 during the pretreatment period ( ° ; n = 18)
and after intramuscular injection of RU 486 (2 mg/kg BW) at 0800 hours on day 277 and again on day
278 (n; n = 12) compared with those in diluent-treated controls (Ÿ; n = 6). (B) Peripheral plasma
concentrations of relaxin during the pretreatment period ( ° ; n = 18), and after subcutaneous injection
of relaxin (3,000 units) at 0800 hours on day 278 (n; n = 6), compared with those in diluent-treated
controls (Ÿ; n = 12). Blood was collected at 15-, 30-, and 60-min intervals immediately after hormone
or placebo treatment and at 2000 and 2400 hours those same days. The times of hormone and diluent
treatments are indicated by open arrows. Values are the mean    + SE.
Figure 2. Comparison of (A) RU 486 and (B) relaxin in peripheral plasma during late pregnancy in
sheep. On day 140, an indwelling catheter was inserted into a jugular vein for repeated blood sample
collection from days 140-143 and day of lambing to two days postpartum. Blood was collected once a
day at 1200 hours; on days 144 and 145 at 1200 hours, the ewes were injected with (A) RU 486 (4
mg/kg BW, intramuscular), and (B) relaxin (3,000 units, intramuscular).  The controls received
intramuscular injections of 3 ml diluent. Blood was collected at -60, -45, -30, -15 min before
treatment and immediately after treatment at 15, 30, 45, 60 min and at 2, 3, 9, and 15 hours.  ( ° ) ;
pretreatment (n = 22); (n); treatment with RU 486 (4 mg/kg BW; intramuscular, n = 5); (l), treatment
with 3,000 U relaxin (intramuscular, n = 9); (Ÿ ), diluent-treated controls (n = 8). The times of hormone
and diluent treatments are indicated by open arrows. Values are the mean –  SE.
